These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 917827)
21. [Antiarrhythmic properties of lidoflazine in the therapy of auricular fibrillation and flutter (clinical studies of 26 patients)]. Lehmann HU; Hochrein H Z Kardiol; 1975 Aug; 64(8):741-8. PubMed ID: 1099831 [TBL] [Abstract][Full Text] [Related]
22. [Protective effects of lidoflazine and mioflazine in ischemic myocardium]. Liu GS; Borgers M; Xhonneux R Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):100-2, 127. PubMed ID: 3197595 [No Abstract] [Full Text] [Related]
23. [Possibilities and trends in pharmacotherapy of cardiac arrhythmias in childhood and adolescence. 2: Anti-arrhythmia agents and anti-arrhythmia active drugs in the present and future]. Mücke D Z Arztl Fortbild (Jena); 1988; 82(6):251-4. PubMed ID: 3043927 [No Abstract] [Full Text] [Related]
24. [Conversion of atrial fibrillation in sinus rhythm with lidoflazine and DC impulses]. Cikos J; Topalov V; Trifunović S; Vodopivec Z Med Pregl; 1982; 35(9-10):341-4. PubMed ID: 7185026 [No Abstract] [Full Text] [Related]
25. The role of monoamine oxidase inhibitors in experimental auricular arrhythmia. Agarwal SL; Deepak B; Natu MV Indian J Med Res; 1968 Jan; 56(1):57-60. PubMed ID: 5666049 [No Abstract] [Full Text] [Related]
26. [Use of lidoflazin in the treatment of ischemic heart disease]. Fomina AA; Mironova KA; Glomozda NIa; Klimovich MD Vrach Delo; 1977 Mar; (3):68-71. PubMed ID: 855300 [No Abstract] [Full Text] [Related]
27. [Choice of anti-arrhythmia agents: the arrhythmia-patient binomial]. Bonhorst D Rev Port Cardiol; 1992 Apr; 11(4):387-9. PubMed ID: 1632996 [No Abstract] [Full Text] [Related]
28. The pathophysiology of angina pectoris and the effect of lidoflazine. Gobel FL; Nordstrom LA; Nelson RR; Wang Y Circulation; 1982 Jan; 65(1 Pt 2):I27-32. PubMed ID: 7030519 [TBL] [Abstract][Full Text] [Related]
29. [Electrophysiological mechanism of arrhythmias and of the most common anti-arrhythmia agents]. Di Blase G; Tabarroni F; Bonavita E; Marzara G; Di Taranto A; Spagna I Boll Soc Ital Cardiol; 1971; 16(9):579-82. PubMed ID: 5150383 [No Abstract] [Full Text] [Related]
30. [Results of treatment of a coronary pain syndrome with lidoflazine]. Dvorák I; Zemánková J; Soják K Vnitr Lek; 1973 Oct; 19(10):943-8. PubMed ID: 4586010 [No Abstract] [Full Text] [Related]
31. [Anti-arrhythmia activity and side effects of various anti-arrhythmia agents]. Storozhuk BG Vrach Delo; 1985 Mar; (3):41-4. PubMed ID: 3892899 [No Abstract] [Full Text] [Related]
32. [Anti-arrhythmia agents in ventricular arrhythmias]. Wever EF; Robles de Medina EO; Hauer RN Ned Tijdschr Geneeskd; 1989 Apr; 133(16):803-8. PubMed ID: 2725733 [No Abstract] [Full Text] [Related]
33. [Therapy of arrhythmias. New anti-arrhythmia agents]. Scholz H Verh Dtsch Ges Herz Kreislaufforsch; 1981; 47():18-33. PubMed ID: 6173967 [No Abstract] [Full Text] [Related]
34. [Fetal cardiac arrhythmia. Clinical experience with anti-arrhythmia drugs]. Blandón R; Leandro IM Rev Med Panama; 1986 May; 11(2):111-23. PubMed ID: 3749536 [No Abstract] [Full Text] [Related]
35. [Treatment of cardiac arrhythmias in aged patients (author's transl)]. Hochrein H Aktuelle Gerontol; 1980 Jan; 10(1):11-6. PubMed ID: 6158269 [TBL] [Abstract][Full Text] [Related]